Full-Time

Senior Software Engineer

DevOps and Observability

Deadline 8/31/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

€50k - €125k/yr

Minna, Inverin, Co. Galway, Ireland

Hybrid

Hybrid work arrangement in Galway, Ireland; some on-site presence may be required.

Bachelor's

Category
DevOps & Infrastructure (2)
,
Software Engineering (1)
Required Skills
Datadog
Claude
Kubernetes
Microsoft Azure
Python
Grafana
GitHub Actions
Java
OpenAI
OpenTelemetry
CloudFormation
Microservices
AWS
Go
Prometheus
Jenkins
Terraform
AppDynamics
Google Cloud Platform

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • 3+ years of experience in software engineering, SRE, or production engineering in large-scale distributed systems
  • Hands-on experience with Observability tools such as AppDynamics, Grafana, Prometheus, Datadog, OpenTelemetry, or similar
  • Experience with AIOps or intelligent monitoring platforms, including anomaly detection and event correlation
  • Strong expertise in cloud platforms (AWS, Azure, or GCP), cloud-native architectures (Kubernetes, containers, microservices), and CI/CD pipelines (GitHub Actions, Jenkins)
  • Proficiency in at least one programming language (e.g., Python, Java, Go)
  • Strong understanding of distributed systems, resiliency patterns, and fault tolerance
  • Experience implementing incident management, on-call processes, and root cause analysis
  • Hands-on expertise with Infrastructure as Code (Terraform, ARM, CloudFormation) and CI/CD pipelines
  • Experience using GenAI/Automation tools and frameworks such as OpenAI, CoPilot, Gemini, Claude, MCP etc.
  • Proven ability to design scalable, reliable, and observable systems
Responsibilities
  • Drive adoption of CI/CD pipelines, Infrastructure as Code (IaC), and GitOps practices
  • Lead the design and evolution of scalable, automated, and secure platform engineering solutions
  • Standardize development and deployment workflows across teams
  • Champion DevOps maturity, developer productivity, and release automation
  • Define and implement enterprise-wide SRE practices, including SLIs, SLOs, error budgets, and reliability governance
  • Drive a culture of reliability, automation, and continuous improvement across engineering teams
  • Establish metrics-driven approaches to measure system health, availability, and performance
  • Lead adoption of AIOps solutions to enable predictive monitoring, anomaly detection, and automated root cause analysis
  • Integrate machine learning models and analytics into monitoring pipelines to proactively detect and prevent incidents
  • Develop intelligent alerting systems to reduce noise and improve signal quality
  • Architect and build scalable observability frameworks covering metrics, logs, traces, and events
  • Define standards for instrumentation, telemetry collection, and distributed tracing
  • Enable real-time insights into system performance across microservices and cloud-native architectures
  • Lead incident response practices, including on-call readiness, RCA, postmortems, and continuous learning loops
  • Build self-healing systems and automate remediation workflows to reduce Mean Time to Resolution (MTTR)
  • Implement runbooks, playbooks, and automated escalations
  • Develop internal platforms and tools for observability, monitoring, and performance optimization
  • Integrate observability into CI/CD pipelines to enable proactive quality and reliability checks
  • Drive infrastructure automation using IaaC frameworks and GitOps principles
  • Partner with engineering, platform, and product teams to embed reliability and observability into system design
  • Mentor engineers and lead design reviews focused on scalability, resilience, and operability
  • Influence enterprise architecture decisions and promote best practices across teams
Desired Qualifications
  • Experience designing and implementing AIOps platforms or predictive reliability systems at scale
  • Strong knowledge of machine learning applications in IT operations (e.g., anomaly detection, forecasting, clustering)
  • Experience defining and managing SLIs/SLOs and error budgets at scale
  • Experience with OpenTelemetry and modern observability standards
  • Familiarity with chaos engineering, resilience testing, and fault injection frameworks
  • Exposure to GenAI-driven operations or AI-assisted troubleshooting tools
  • Experience in healthcare, finance, enterprise SaaS, or highly regulated industries
  • Demonstrated leadership in driving cross-functional initiatives and influencing senior stakeholders
  • Contributions to open-source projects in SRE, observability, or AIOps domains
  • Bachelor’s degree or equivalent work experience in Computer Science, Engineering, or related discipline
  • Certifications in AIOps, SRE, OpenTelemetry, cloud platforms, or DevOps are a plus
  • Leadership Competencies: Strategic thinking and execution excellence; Strong communication and stakeholder influence; Data-driven decision making; Continuous improvement mindset

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.